(LTC) LTC Properties - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5021751020

LTC: Seniors Housing, Skilled Nursing Properties

LTC Properties Inc, a healthcare-focused REIT, specializes in seniors housing and medical real estate. The company deploys capital through a variety of structures: sale-leasebacks, mortgage financing, joint ventures, preferred equity, and mezzanine debt. This diversified approach allows LTC to balance risk and return across different asset classes and operating partners.

The portfolio spans 201 properties across 26 states, with 29 different operating partners. This geographic and operational diversification reduces exposure to any single market or management team. Approximately half of the portfolio is allocated to seniors housing, which includes assisted living and memory care facilities, while the other half is dedicated to skilled nursing properties. This 50/50 split reflects a balanced approach to the healthcare continuum, capturing both the growing demand for senior housing and the steady, if sometimes challenging, skilled nursing sector.

With a market cap of ~$1.56 billion, LTC operates at a mid-sized scale that allows for selective deal-making without being overly constrained by size. The forward P/E of ~12.45 suggests that investors are pricing in moderate growth expectations, while the current P/E of ~14.84 reflects the markets view on recent earnings performance. The price-to-book ratio of 1.65 indicates that investors are paying a modest premium for the companys assets, which could reflect confidence in managements ability to drive value through its investment strategy.

The price-to-sales ratio of ~7.87 highlights the REITs ability to generate consistent cash flows from its lease and lending structures. For investors, LTC offers exposure to the aging demographic trend in the U.S., as well as the potential for attractive yields in a sector with significant barriers to entry. However, the skilled nursing component of the portfolio introduces regulatory and operational risks that must be carefully considered.

Additional Sources for LTC Stock

LTC Stock Overview

Market Cap in USD 1,640m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 1992-08-17

LTC Stock Ratings

Growth 5y 53.7%
Fundamental 54.3%
Dividend 64.1%
Rel. Strength Industry 9.52
Analysts 3.25/5
Fair Price Momentum 37.38 USD
Fair Price DCF 61.58 USD

LTC Dividends

Dividend Yield 12m 7.08%
Yield on Cost 5y 12.04%
Annual Growth 5y 0.00%
Payout Consistency 91.1%

LTC Growth Ratios

Growth Correlation 3m 20.5%
Growth Correlation 12m 63.8%
Growth Correlation 5y 57.9%
CAGR 5y 11.45%
CAGR/Max DD 5y 0.41
Sharpe Ratio 12m 1.27
Alpha 10.67
Beta 0.37
Volatility 21.19%
Current Volume 182.1k
Average Volume 20d 371.6k
What is the price of LTC stocks?
As of March 14, 2025, the stock is trading at USD 35.29 with a total of 182,139 shares traded.
Over the past week, the price has changed by -1.31%, over one month by +2.64%, over three months by -3.43% and over the past year by +16.35%.
Is LTC Properties a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, LTC Properties (NYSE:LTC) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.25 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LTC as of March 2025 is 37.38. This means that LTC is currently overvalued and has a potential downside of 5.92%.
Is LTC a buy, sell or hold?
LTC Properties has received a consensus analysts rating of 3.25. Therefor, it is recommend to hold LTC.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
What are the forecast for LTC stock price target?
According to ValueRays Forecast Model, LTC LTC Properties will be worth about 40.4 in March 2026. The stock is currently trading at 35.29. This means that the stock has a potential upside of +14.4%.
Issuer Forecast Upside
Wallstreet Target Price 38 7.7%
Analysts Target Price 37.6 6.5%
ValueRay Target Price 40.4 14.4%